Technical Analysis for NVLN - Novelion Therapeutics Inc.

Grade Last Price % Change Price Change
grade F 1.19 0.00% 0.00
NVLN closed unchanged on Monday, May 20, 2019, on 53 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical NVLN trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
Oversold Stochastic Weakness 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Stochastic Reached Oversold Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
180 Bearish Setup Bearish Swing Setup 2.59%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 2.59%
Lower Bollinger Band Walk Weakness 2.59%

Older signals for NVLN ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Novelion Therapeutics Inc, formerly QLT Inc., is a Canada-based biopharmaceutical company. The Company is engaged in development of new standards of care for individuals living with rare diseases. The Company is focused on advancing its portfolio of rare disease therapies by investing in science and clinical development. The Company holds a portfolio of products through its subsidiary, Aegerion Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases. The Company's portfolio of products include MYALEPT and JUXTAPID. The Company is also developing zuretinol acetate for the treatment of inherited retinal disease caused by underlying mutations in RPE65 or LRAT genes.
Biotechnology Biopharmaceutical Life Sciences Pharmaceutical Industry Pharmacy Rare Diseases Retinal Disease
Is NVLN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 4.79
52 Week Low 0.7
Average Volume 127,220
200-Day Moving Average 1.6521
50-Day Moving Average 1.2846
20-Day Moving Average 1.2565
10-Day Moving Average 1.209
Average True Range 0.0738
ADX 19.36
+DI 14.2028
-DI 17.6374
Chandelier Exit (Long, 3 ATRs ) 1.1886
Chandelier Exit (Short, 3 ATRs ) 1.3614
Upper Bollinger Band 1.3777
Lower Bollinger Band 1.1353
Percent B (%b) 0.23
BandWidth 19.291683
MACD Line -0.036
MACD Signal Line -0.0262
MACD Histogram -0.0098
Fundamentals Value
Market Cap 22.19 Million
Num Shares 18.6 Million
EPS -5.12
Price-to-Earnings (P/E) Ratio -0.23
Price-to-Sales 1.11
Price-to-Book 1.08
PEG Ratio 0.13
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.24
Resistance 3 (R3) 1.23 1.22 1.23
Resistance 2 (R2) 1.22 1.21 1.22 1.22
Resistance 1 (R1) 1.20 1.20 1.21 1.21 1.22
Pivot Point 1.19 1.19 1.19 1.19 1.19
Support 1 (S1) 1.17 1.18 1.18 1.18 1.16
Support 2 (S2) 1.16 1.17 1.16 1.16
Support 3 (S3) 1.14 1.16 1.15
Support 4 (S4) 1.15